Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing α-fetoprotein

Journal of Gastroenterology

Volumn 38, Issue 6, 2003, Pages 540-547

  Kamei, Shigeo ^a   Kono, Koji ^a   Amemiya, Hideki ^a   Takahashi, Akihiro ^a   Sugai, Hidemitsu ^a   Ichihara, Fumiko ^a   Fujii, Hideki ^a   Matsumoto, Yoshirou ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

AFP; Gastric cancer; VEGF; VEGF C

Indexed keywords

ALPHA FETOPROTEIN; VASCULOTROPIN; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULARIZATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VASCULARIZATION;

EID: 0038103010     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-002-1099-y     Document Type: Article

References (28)

1. Bergstrand CG, Czar D. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956;8:174.
2. Ruoslahti E, Engvall E, Seppala M. Developmental change in carbohydrate moiety of human alpha-feto-protein. Int J Cancer 1978;22:515-20.
3. O'Conor GT, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970;25:1091-8.
4. Motoyama T, Watanabe H, Yamamoto T, Sekiguchi M. Production of alpha-fetoprotein by human germ cell tumors in vivo and in vitro. Acta Pathol Jpn 1987;37:1263-77.
5. McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum α-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975;35:991-6.
6. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence d'Alpha Foetoproteine au cours d'un cancer secondaire du foie d'origine gastrique. Presse Med 1970;78:1277-8.
7. Chang YC, Nagasue N, Abe S, Kohno H, Yamanoi A, Uchida M, et al. The characters of AFP-producing early gastric cancer. J Jpn Surg Soc 1990;91:1574-80.
8. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K. α-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn 1993;43:654-61.
9. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992;87:321-5.
10. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 2000;59:145-51.
11. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. α-Fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol 1999;94:1658-63.
12. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
13. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84;1470-8.
14. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000;6:572-7.
15. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-63.
16. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998;78:1573-7.
17. Fine BA, Valente PT, Feinstein GI, Dey T. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Gynecol Oncol 2000;76:33-9.
18. Fontanini G, Faviana P, Lucchi M, Boldrini L, Mussi A, Camacci T, et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. Br J Cancer 2002;86:558-63.
19. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-5.
20. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5:1823-9.
21. Akagi K, Ikeda Y, Miyasaki M, Abe T, Kinoshita J, Maehara Y, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000;83:887-91.
22. Takahashi A, Kono K, Itakura J, Amemiya H, Tang RF, Iizuka H, et al. Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer. Oncology 2002;62:121-7.
23. Amemiya H, Kono K, Takahashi A, Kamei S, Sugai H, Ichihara F, et al. c-Met expression in gastric cancer cell line producing α-fetoprotein. Oncology 2003; in press.
24. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelia growth factor by increasing hypoxia-inducible factor-1 alpha in ovarian carcinoma cells. J Biol Chem 2002;277:27850-5.
25. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, et al. Comparison of VEGF, VEGF-B, BEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14:2475-83.
26. Ponzetto C, Giordano S, Peverali F, Della Valle G, Abate ML, Vaula G, et al. c-Met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 1991;6:553-5.
27. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-44.
28. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989;4:1383-8.